Benefícios Cardiovasculares da Semaglutida Oral episode artwork

EPISODE · May 15, 2025 · 8 MIN

Benefícios Cardiovasculares da Semaglutida Oral

from Rádio UPF + · host Rádio UPF

O Instituto Méderi, como sede em Passo fundo, contribuiu com um estudo inovador que revelou benefícios cardiovasculares para quem tomou semaglutida Oral. Conversamos com a Diretora Executiva do Instituto Méderi de Pesquisa e Saúde, farmacêutica bioquímica, mestre em saúde e professora da Escola de Medicina da UPF, Keila Deucher.

Episode metadata supplied by the publisher feed · Published May 15, 2025

Embed this episode

NOW PLAYING

Benefícios Cardiovasculares da Semaglutida Oral

0:00 8:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Rádio UPF +?

This episode is 8 minutes long.

When was this Rádio UPF + episode published?

This episode was published on May 15, 2025.

Can I download this Rádio UPF + episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!